Article Versions Notes

Mahmud Z, Gomes AR, Lee HJ, Aimjongjun S, Jiramongkol Y, Yao S, Zona S, Alasiri G, Gong G, Yagüe E, et al. EP300 and SIRT1/6 Co-Regulate Lapatinib Sensitivity Via Modulating FOXO3-Acetylation and Activity in Breast Cancer. Cancers. 2019; 11(8):1067. https://doi.org/10.3390/cancers11081067

Mahmud, Zimam, Ana R. Gomes, Hee Jin Lee, Sathid Aimjongjun, Yannasittha Jiramongkol, Shang Yao, Stefania Zona, Glowi Alasiri, Gyungyub Gong, Ernesto Yagüe, and et al. 2019. "EP300 and SIRT1/6 Co-Regulate Lapatinib Sensitivity Via Modulating FOXO3-Acetylation and Activity in Breast Cancer" Cancers 11, no. 8: 1067. https://doi.org/10.3390/cancers11081067

Mahmud, Z., Gomes, A. R., Lee, H. J., Aimjongjun, S., Jiramongkol, Y., Yao, S., Zona, S., Alasiri, G., Gong, G., Yagüe, E., & Lam, E. W.-F. (2019). EP300 and SIRT1/6 Co-Regulate Lapatinib Sensitivity Via Modulating FOXO3-Acetylation and Activity in Breast Cancer. Cancers, 11(8), 1067. https://doi.org/10.3390/cancers11081067